MARGUERITE MARSCHNER: Open Payments
NPI 1295162444 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 47 payments from 8 companies in 2025. Trend: 2023 $528 · 2024 $826 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $384 |
| Janssen Biotech, Inc. | 7 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| GENZYME CORPORATION | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Celltrion USA Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $16 |
Products named: RINVOQ, TREMFYA, DUPIXENT, CREON, ENTYVIO, SKYRIZI, XELJANZ, VEGZELMA.
Industry payments across LA — which companies pay providers there.
